SCHEMBL31093121

SCHEMBL31093121

C=C(CCN1CCN(C)CC1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.62
SLC6A3 Q01959 2/20 0.62
MC4R P32245 1/20 0.49
RAB9A P51151 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
SIGMAR1 Q99720 3/20 0.47
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 1/20 0.46
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
GFER P55789 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31093199 0.94 SLC6A4 (0.57) SLC6A4SLC6A3MC4RRAB9ANPSR1
SCHEMBL31093170 0.93 SLC6A4 (0.69) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL1903553 0.86 ALDH1A1 (0.62) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL9779110 0.84 ALDH1A1 (0.65) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL31093117 0.83 SLC6A4 (0.59) SLC6A4SLC6A3SIGMAR1
SCHEMBL31092907 0.81 SLC6A4 (0.57) SLC6A4SLC6A3RAB9ASIGMAR1ALDH1A1
SCHEMBL9779465 0.81 ALDH1A1 (0.67) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL31092931 0.81 SLC6A4 (0.57) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL3893679 0.79 KMT2A (0.73) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A
SCHEMBL31092974 0.79 SLC6A4 (0.54) SLC6A4SLC6A3SIGMAR1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035497-A1 AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-02-05 US claimed
US-20260035495-A1 FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF Kraton Corporation (US) 2026-02-05 US claimed
US-20260035493-A1 AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-02-05 US claimed
US-20260028457-A1 AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-01-29 US claimed
US-20250250379-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2025-08-07 US claimed
EP-4596661-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF Infineum International Limited (GB) 2025-08-06 EP claimed
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME INFINEUM INTERNATIONAL LIMITED (GB) 2024-08-29 US claimed
EP-4410772-A2 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME Infineum International Limited (GB) 2024-08-07 EP claimed
CN-118440229-A Amine functional monomers and methods of making the same 英菲诺姆国际有限公司 2024-08-06 CN claimed
EP-4596662-B1 AMINE CONTAINING POLYMERS AND LUBRICANT COMPOSITIONS INCLUDING SUCH POLYMERS AND METHODS OF USING THEREOF INFINEUM INT LTD (GB) 2026-04-29 EP disclosed
US-20260035497-A1 AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-02-05 US disclosed
US-20260035493-A1 AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-02-05 US disclosed
US-20260028457-A1 AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2026-01-29 US disclosed
US-20250250380-A1 AMINE CONTAINING POLYMERS AND LUBRICANT COMPOSITIONS INCLUDING SUCH POLYMERS AND METHODS OF USING THEREOF INFINEUM INTERNATIONAL LIMITED 2025-08-07 US disclosed
US-20250250379-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2025-08-07 US disclosed
EP-4596662-A1 AMINE CONTAINING POLYMERS AND LUBRICANT COMPOSITIONS INCLUDING SUCH POLYMERS AND METHODS OF USING THEREOF Infineum International Limited (GB) 2025-08-06 EP disclosed
EP-4596661-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF Infineum International Limited (GB) 2025-08-06 EP disclosed
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME INFINEUM INTERNATIONAL LIMITED (GB) 2024-08-29 US disclosed
EP-4410772-A2 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME Infineum International Limited (GB) 2024-08-07 EP disclosed
CN-118440229-A Amine functional monomers and methods of making the same 英菲诺姆国际有限公司 2024-08-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035495-A1 FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF VCL, FGB, CDH1 SLC6A4 4190/4885SLC6A3 3824/4885MC4R 4849/4885
US-20260035493-A1 AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF CBS, SELP, RAD51 SLC6A4 967/4885SLC6A3 1604/4885MC4R 4181/4885
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME AMD1, HNMT, MAT1A SLC6A4 2274/4885SLC6A3 2219/4885MC4R 4543/4885
US-20260035497-A1 AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF DEGS1, SGMS1, PHOSPHO1 SLC6A4 2459/4885SLC6A3 3038/4885MC4R 4072/4885
US-20250250380-A1 AMINE CONTAINING POLYMERS AND LUBRICANT COMPOSITIONS INCLUDING SUCH POLYMERS AND METHODS OF USING THEREOF C1S, SELP, C9 SLC6A4 3309/4885SLC6A3 3416/4885MC4R 3592/4885
US-20260028457-A1 AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF DEGS1, PHOSPHO1, NAPEPLD SLC6A4 3112/4885SLC6A3 2986/4885MC4R 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.